Search research articles
Contact Us
Filters
Showing results (1021-1030 of 1,043) with videos related to
Page
of 105
Sort By:
Annals of Surgical Oncology
|
February 1, 2021
A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival
Richard S Hoehn, Caroline J Rieser, Sharon Winters, et al.
Journal of the American College of Cardiology
|
May 27, 2026
The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC)
Zhiqi Yao, Zeina A Dardari, Michael J LaMonte, et al.
Cancer Immunology Research
|
July 27, 2022
Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054
Richard Tavaré, Makenzie Danton, Jason T Giurleo, et al.
Critical Care Medicine
|
April 13, 2023
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations
Rahul Nanchal, Ram Subramanian, Waleed Alhazzani, et al.
Journal of Microbiology (Seoul, Korea)
|
October 3, 2015
Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection
Colin M Dinney, Lu-Dong Zhao, Charles D Conrad, et al.
Critical Care Medicine
|
February 15, 2020
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations
Rahul Nanchal, Ram Subramanian, Constantine J Karvellas, et al.
Cell Reports. Medicine
|
September 26, 2024
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies
Jiaxi Wu, Nicolin Bloch, Aaron Y Chang, et al.
Nature Genetics
|
May 5, 2022
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk
Constance Baer, Shunsuke Kimura, Mitra S Rana, et al.
Science (New York, N.Y.)
|
October 15, 2011
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield
Robert Pejchal, Katie J Doores, Laura M Walker, et al.
Transplantation
|
June 23, 2020
When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts
Emmanuel Weiss, Fuat Saner, Sumeet K Asrani, et al.
Page
of 105
Search research articles
Search
Showing results (1021-1030 of 1,043) with videos related to
Sort By:
Page
of 105
Annals of Surgical Oncology
|
February 1, 2021
A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival
Richard S Hoehn, Caroline J Rieser, Sharon Winters, et al.
Journal of the American College of Cardiology
|
May 27, 2026
The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC)
Zhiqi Yao, Zeina A Dardari, Michael J LaMonte, et al.
Cancer Immunology Research
|
July 27, 2022
Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054
Richard Tavaré, Makenzie Danton, Jason T Giurleo, et al.
Critical Care Medicine
|
April 13, 2023
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations
Rahul Nanchal, Ram Subramanian, Waleed Alhazzani, et al.
Journal of Microbiology (Seoul, Korea)
|
October 3, 2015
Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection
Colin M Dinney, Lu-Dong Zhao, Charles D Conrad, et al.
Critical Care Medicine
|
February 15, 2020
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations
Rahul Nanchal, Ram Subramanian, Constantine J Karvellas, et al.
Cell Reports. Medicine
|
September 26, 2024
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies
Jiaxi Wu, Nicolin Bloch, Aaron Y Chang, et al.
Nature Genetics
|
May 5, 2022
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk
Constance Baer, Shunsuke Kimura, Mitra S Rana, et al.
Science (New York, N.Y.)
|
October 15, 2011
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield
Robert Pejchal, Katie J Doores, Laura M Walker, et al.
Transplantation
|
June 23, 2020
When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts
Emmanuel Weiss, Fuat Saner, Sumeet K Asrani, et al.
Page
of 105